Skip to search formSkip to main contentSkip to account menu

Copegus

National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Ribavirin
Ribavirin 200 MG Oral Tablet [Copegus]Ribavirin Oral Tablet [Copegus]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
COMBINED ANTIVIRAL TREATMENT OF HEPATITIS C VIRUS INFECTION WITH PEGYLATED INTERFERON (PEG-IFN) Α-2A (PEGFERON) AND RIBAVIRIN (COPEGUS) IN INMATES.
The aim of the study was to assess the impact of combined antiviral therapy in prisoners with HCV. In total, 210 patients with… 
2015
2015
Bioequivalence study of Ribavirin 400 mg tablets in healthy Thai male volunteers under fed conditions
Ribavirin is a nucleoside analogue that exerts an antiviral activity. It mostly uses as a combination with interferon alfa-2b for… 
2009
2009
Low-dose IL-2 therapy reduces HCV RNA and HBV DNA: case report.
BACKGROUND Patients with concomitant hepatitis C (HCV) and B (HBV) infection are difficult to treat due to lack of medicines that… 
2005
2005
An evaluation of the cost-effectiveness of peginterferon alfa-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) for the first treatment of mild chronic hepatitis C (CHC)
2003
2003
Treatment of patients with chronic hepatitis C (CHC) with peginterferon alfa-2a (40KD) (Pegasys) alone or in combination with ribavirin (copegus) results in long-lasting sustained virological…
2003
2003
Predictors of virologic relapse in patients with chronic hepatitis C (CHC) treated with peginterferon alfa-2a (40KD) (pegasys) alone or in combination with ribavirin (copegus)
2003
2003
A comparison of cost-effectiveness of peginterferon alfa-2a (40KD) (Pegasys) plus ribavirin (copegus) vs interferon alfa-2b plus ribavirin as first treatment of chronic hepatitus C (CHC)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)